Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bock

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potencyP D Williams, M G Bock, B E Evans, et al.
Journal of Medicinal Chemistry|November 26, 1997
Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 positionD M Feng, S J Gardell, S D Lewis, et al.
European Journal of Pharmacology|September 15, 2004
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonistRichard W Ransom, Charles M Harrell, Duane R Reiss, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel AntagonistsJames C Barrow, Kenneth E Rittle, Thomas S Reger, et al.
Journal of Medicinal Chemistry|January 19, 2007
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonistsScott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Journal of Medicinal Chemistry|May 2, 2003
Benzodiazepines as potent and selective bradykinin B1 antagonistsMichael R Wood, June J Kim, Wei Han, et al.
Journal of Medicinal Chemistry|June 11, 2008
Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonistWilliam D Shipe, James C Barrow, Zhi-Qiang Yang, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channelsZhi-Qiang Yang, James C Barrow, William D Shipe, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Bioorganic & Medicinal Chemistry Letters|August 3, 2010
Discovery and expanded SAR of 4,4-disubstituted quinazolin-2-ones as potent T-type calcium channel antagonistsKelly-Ann S Schlegel, Zhi-Qiang Yang, Thomas S Reger, et al.
Bioorganic & Medicinal Chemistry Letters|May 26, 1999
Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potencyP D Williams, M G Bock, B E Evans, et al.
Journal of Medicinal Chemistry|November 26, 1997
Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 positionD M Feng, S J Gardell, S D Lewis, et al.
European Journal of Pharmacology|September 15, 2004
Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonistRichard W Ransom, Charles M Harrell, Duane R Reiss, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of 4,4-Disubstituted Quinazolin-2-ones as T-Type Calcium Channel AntagonistsJames C Barrow, Kenneth E Rittle, Thomas S Reger, et al.
Journal of Medicinal Chemistry|January 19, 2007
Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonistsScott D Kuduk, Christina N Di Marco, Ronald K Chang, et al.
Journal of Medicinal Chemistry|May 2, 2003
Benzodiazepines as potent and selective bradykinin B1 antagonistsMichael R Wood, June J Kim, Wei Han, et al.
Journal of Medicinal Chemistry|June 11, 2008
Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonistWilliam D Shipe, James C Barrow, Zhi-Qiang Yang, et al.
Bioorganic & Medicinal Chemistry Letters|December 7, 2007
Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonistsMichael R Wood, Kathy M Schirripa, June J Kim, et al.
Journal of Medicinal Chemistry|September 27, 2008
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channelsZhi-Qiang Yang, James C Barrow, William D Shipe, et al.
Pageof 21